Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Healthtrust
Moodys
Covington
Julphar
Fuji
Farmers Insurance
Federal Trade Commission

Generated: July 22, 2018

DrugPatentWatch Database Preview

VERSACLOZ Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Versacloz, and what generic alternatives are available?

Versacloz is a drug marketed by Tasman Pharma and is included in one NDA.

The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the clozapine profile page.
Drug patent expirations by year for VERSACLOZ
Pharmacology for VERSACLOZ
Medical Subject Heading (MeSH) Categories for VERSACLOZ
Synonyms for VERSACLOZ
1333667-72-3
3-chloro-6-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine
3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
3-Hydroxy-2-phenyl-propionic acid 8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester
5786-21-0
5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-
5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-
6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1,3(8),4,6,10,12,14-heptaene
6-CHLORO-10-(4-METHYLPIPERAZIN-1-YL)-2,9-DIAZATRICYCLO[9.4.0.0(3),?]PENTADECA-1,3(8),4,6,10,12,14-HEPTAENE
6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0(3),]pentadeca-1,3,5,7,10,12,14-heptaene
6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,9,12,14-heptaene
786C210
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
8-chloro-11-(4-methyl-piperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine (Clozapine)
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine( Clozepine )
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(Ciozapine)
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(Clopazine)
8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine
8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methylpiperazino)-5H-dibenzo[b,e][1,4]diazepine
AB00052158_15
AB00052158_16
AB00052158-13
AB00052158-14
AB0013069
AB1009321
AC1L1EJE
AC1Q3OPZ
AC1Q3ZWP
AKOS005064444
AKOS026749900
AN-16004
ANW-42470
AOB5635
Asaleptin
Azaleptin
Azaleptine
BC204168
BDBM22869
BDBM50001884
BG0154
Bio1_000436
Bio1_000925
Bio1_001414
Bio2_000310
Bio2_000790
BRD-K37289225-001-09-1
BRN 0764984
C 6305
C-36335
C06924
C18H19ClN4
CAS-5786-21-0
CC0176
CCG-39881
CCRIS 9171
CHEBI:3766
CHEBI:92657
CHEMBL42
Clopine (TN)
Clorazil
Clozapin
Clozapina
Clozapina [INN-Spanish]
clozapine
Clozapine (Clozaril)
Clozapine (JAN/USP/INN)
Clozapine [USAN:INN:BAN]
Clozapine [USAN:USP:INN:BAN]
Clozapine 1.0 mg/ml in Acetonitrile
Clozapine for peak identification, European Pharmacopoeia (EP) Reference Standard
Clozapine Resolution Mixture, United States Pharmacopeia (USP) Reference Standard
CLOZAPINE, 8-CHLORO-11-(4-METHYL-PIPERAZIN-1-YL)-5H-DIBENZO[B,E][1,4]DIAZEPINE
Clozapine, British Pharmacopoeia (BP) Reference Standard
Clozapine, drug standard, 1.0 mg/mL in methanol
Clozapine, European Pharmacopoeia (EP) Reference Standard
Clozapine, solid
Clozapine, United States Pharmacopeia (USP) Reference Standard
clozapine(tautomer)
Clozapinum
Clozapinum [INN-Latin]
CLOZARIL
Clozaril (TN)
CPD000058365
CS-0644
CTK6I2968
D-107
D00283
D0Z1RV
DB00363
Denzapine (TN)
DivK1c_000343
DSSTox_CID_2855
DSSTox_GSID_22855
DSSTox_RID_76759
DTXSID5022855
EINECS 227-313-7
EN300-52510
EU-0100276
Fazaclo
Fazaclo (TN)
Fazaclo ODT
Froidir (TN)
FT-0082373
FT-0600382
GP7633
GTPL38
H482
HF 1854
HF-1854
HF1854
HMS1361P12
HMS1569E21
HMS1791P12
HMS1921C16
HMS1989P12
HMS2089L13
HMS2092I16
HMS2096E21
HMS2235E19
HMS3259J17
HMS3260H14
HMS3266A10
HMS3371H05
HMS3402P12
HMS3657E15
HMS501B05
HSDB 6478
HY-14539
I06-0047
Iprox
J60AR2IKIC
KBio1_000343
KBio2_000310
KBio2_000599
KBio2_002878
KBio2_003167
KBio2_005446
KBio2_005735
KBio3_000619
KBio3_000620
KBio3_002979
KBioGR_000310
KBioGR_001336
KBioSS_000310
KBioSS_000599
Klozapol
Klozapol (TN)
KS-1166
L000195
L013417
Leponex
Leponex (TN)
Lepotex
LEX-123
Lopac-C-6305
LP00276
LS-60881
LX 100-129
MCULE-3665900006
MFCD00153785
MLS000028472
MLS001077282
MolPort-001-728-041
MolPort-006-167-528
NC00667
NCGC00015254-01
NCGC00015254-02
NCGC00015254-03
NCGC00015254-04
NCGC00015254-05
NCGC00015254-06
NCGC00015254-07
NCGC00015254-08
NCGC00015254-09
NCGC00015254-10
NCGC00015254-11
NCGC00015254-12
NCGC00015254-13
NCGC00015254-14
NCGC00015254-15
NCGC00015254-16
NCGC00015254-17
NCGC00015254-18
NCGC00015254-20
NCGC00022902-02
NCGC00022902-04
NCGC00022902-05
NCGC00022902-06
NCGC00022902-07
NCGC00022902-08
NCGC00022902-09
NCGC00022902-10
NCGC00022902-11
NCGC00022902-12
NCGC00022902-13
NCGC00188978-01
NCGC00260961-01
NINDS_000343
NSC-757429
NSC757429
Opera_ID_482
Pharmakon1600-01500685
PL001733
Prestwick_693
Prestwick0_000350
Prestwick1_000350
QZUDBNBUXVUHMW-UHFFFAOYSA-N
REGID_for_CID_2818
s2459
SAM002548976
SAM002589962
SBI-0050264.P004
SC-12183
SC-26976
SCHEMBL33323
SCHEMBL8397
SMR000058365
SPBio_000798
SPBio_002340
Spectrum_000139
SPECTRUM1500685
Spectrum2_000919
Spectrum3_001828
Spectrum4_000898
SR-01000000096
SR-01000000096-2
TC-063560
Tocris-0444
Tox21_110113
Tox21_110113_1
Tox21_500276
UNII-J60AR2IKIC
W-105432
W-2845
W-801
Z1245633277
Zaponex (TN)
ZINC19796155
ZINC3872123

US Patents and Regulatory Information for VERSACLOZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tasman Pharma VERSACLOZ clozapine SUSPENSION;ORAL 203479-001 Feb 6, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Chubb
Express Scripts
AstraZeneca
Johnson and Johnson
Fish and Richardson
Mallinckrodt
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.